SCHEMBL13610484

SCHEMBL13610484

CCC(C(=O)NCCS)N1C(=O)C=CC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ THRB P10828 1/20 0.32
▸ HDAC3 O15379 2/20 0.31
▸ HDAC4 P56524 2/20 0.31
▸ HDAC1 Q13547 2/20 0.31
▸ HDAC7 Q8WUI4 2/20 0.31
▸ HDAC2 Q92769 2/20 0.31
▸ HDAC10 Q969S8 2/20 0.31
▸ HDAC11 Q96DB2 2/20 0.31
▸ HDAC8 Q9BY41 2/20 0.31
▸ HDAC6 Q9UBN7 2/20 0.31
▸ HDAC9 Q9UKV0 2/20 0.31
▸ HDAC5 Q9UQL6 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28646996 0.84 TSHR (0.35) TSHRUSP2AKT1THRBCYP1A2
SCHEMBL14217890 0.82 ALDH1A1 (0.40) TSHRUSP2AKT1THRBHDAC3
SCHEMBL25682469 0.75 L3MBTL1 (0.34) TSHRUSP2AKT1THRBPOLB
SCHEMBL964946 0.72 DNMT1 (0.44) TP53HSD17B10POLBALDH1A1CYP1A2
SCHEMBL11975541 0.72 MGLL (0.38) TP53ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL5161621 0.71 ALDH1A1 (0.42) TP53ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL20887626 0.71 PKM (0.33) TSHRALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL23805314 0.71 HDAC3 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6567846 0.71 LMNA (0.47) TP53POLBALDH1A1CYP1A2HPGD
SCHEMBL21648874 0.70 ANPEP (0.44) THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325262-A1 Immobilization of biological molecules onto surfaces coated with monolayers SURFACE LOGIX, INC. 2009-12-31 — — US disclosed
US-7439056-B2 Peelable and resealable devices for arraying materials SURFACE LOGIX INC. (US) 2008-10-21 — — US disclosed
US-7351575-B2 Methods for processing biological materials using peelable and resealable devices SURFACE LOGIX, INC. (US) 2008-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325262-A1 Immobilization of biological molecules onto surfaces coated with monolayers EPCAM, ICAM1, MB TSHR 887/4885USP2 1131/4885AKT1 4538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback